Publicaciones en las que colabora con M. Angeles Castilla Moro (15)

2016

  1. CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy

    Histopathology, Vol. 69, Núm. 2, pp. 239-249

  2. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

    Oncotarget, Vol. 7, Núm. 35, pp. 56295-56308

  3. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

    Oncogene, Vol. 35, Núm. 21, pp. 2777-2788

2015

  1. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503

  2. Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer

    Endocrine-Related Cancer, Vol. 22, Núm. 3, pp. 443-454

2014

  1. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition

    Journal of Pathology, Vol. 232, Núm. 3, pp. 319-329

  2. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer

    Endocrine-Related Cancer, Vol. 21, Núm. 4, pp. 587-599

2013

  1. Genetics of endometrial carcinoma

    Cancer Genomics: Molecular Classification, Prognosis and Response Prediction (Springer Netherlands), pp. 349-390

  2. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

    Human Pathology, Vol. 44, Núm. 2, pp. 244-254

  3. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

    Modern Pathology, Vol. 26, Núm. 11, pp. 1514-1524

2012

  1. MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

    PLoS ONE, Vol. 7, Núm. 10

2011

  1. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

    EMBO Molecular Medicine, Vol. 3, Núm. 9, pp. 528-544

  2. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

    Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80

2008

  1. The molecular pathology of hereditary breast cancer

    Pathobiology, Vol. 75, Núm. 2, pp. 85-94

  2. Wilms' tumour: A complex enigma to decipher

    Clinical and Translational Oncology, Vol. 10, Núm. 8, pp. 457-461